Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the surface glycoprotein interaction network by integrating chemical crosslinking with MS-based proteomics. | Chem Sci | 2021 | 34163979 | PubTator, text mining | PubMed |
| Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease. | Sci Rep | 2021 | 34162989 | PubTator, text mining | PubMed |
| Sex-specific expression mechanism of hepatic estrogen inactivating enzyme and transporters in diabetic women. | Biochem Pharmacol | 2021 | 34157297 | PubTator, text mining | PubMed |
| Coronaviruses, cholesterol and statins: Involvement and application for Covid-19. | Biochimie | 2021 | 34153377 | PubTator, text mining | PubMed |
| Pharmacokinetics of gallic acid and protocatechuic acid in humans after dosing with Relinqing (RLQ) and the potential for RLQ-perpetrated drug-drug interactions on organic anion transporter (OAT) 1/3. | Pharm Biol | 2021 | 34144662 | PubTator, text mining | PubMed |
| Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes. | Pharmacogenomics | 2021 | 34142560 | PubTator, text mining | PubMed |
| The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors. | Front Oncol | 2021 | 34141613 | PubTator, text mining | PubMed |
| Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy. | J Hepatocell Carcinoma | 2021 | 34136422 | PubTator, text mining | PubMed |
| SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a 177Lu-DOTA-Integrin αvβ6 Cystine Knot Peptide in a Pancreatic Cancer Xenograft Model. | Front Oncol | 2021 | 34136410 | PubTator, text mining | PubMed |
| Evaluation of population-level pharmacogenetic actionability in Alabama. | Clin Transl Sci | 2021 | 34121327 | PubTator, text mining | PubMed |
| Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin. | Clin Pharmacol Ther | 2021 | 34114646 | PubTator, text mining | PubMed |
| Understanding the Pathogenesis of Gestational Hypothyroidism. | Front Endocrinol (Lausanne) | 2021 | 34113317 | PubTator, text mining | PubMed |
| Data-Driven Ensemble Docking to Map Molecular Interactions of Steroid Analogs with Hepatic Organic Anion Transporting Polypeptides. | J Chem Inf Model | 2021 | 34105971 | PubTator, text mining | PubMed |
| Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients. | CPT Pharmacometrics Syst Pharmacol | 2021 | 34102029 | PubTator, text mining | PubMed |
| Interactions between cardiology and oncology drugs in precision cardio-oncology. | Clin Sci (Lond) | 2021 | 34076246 | PubTator, text mining | PubMed |
| Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors. | Int J Mol Sci | 2021 | 34071338 | PubTator, text mining | PubMed |
| Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods. | Molecules | 2021 | 34070985 | PubTator, text mining | PubMed |
| In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach. | Int J Mol Sci | 2021 | 34068678 | PubTator, text mining | PubMed |
| Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance. | Pharmaceuticals (Basel) | 2021 | 34065757 | PubTator, text mining | PubMed |
| Application of a PBPK model to elucidate the changes of systemic and liver exposures for rosuvastatin, carotegrast, and bromfenac followed by OATP inhibition in monkeys. | Clin Transl Sci | 2021 | 34058067 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=41